vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 käytettävissä olevista tiedoista eri yhdistelmistä).
vildagliptin/metformin krka 50 mg / 1000 mg tabletti, kalvopäällysteinen
krka, d.d., novo mesto - metformin hydrochloride, vildagliptin - tabletti, kalvopäällysteinen - 50 mg / 1000 mg - metformiini ja vildagliptiini
vildagliptin/metformin krka 50 mg / 850 mg tabletti, kalvopäällysteinen
krka, d.d., novo mesto - metformin hydrochloride, vildagliptin - tabletti, kalvopäällysteinen - 50 mg / 850 mg - metformiini ja vildagliptiini
vildagliptin/metformin ratiopharm 50 mg / 850 mg tabletti, kalvopäällysteinen
teva b.v. - metformin hydrochloride, vildagliptin - tabletti, kalvopäällysteinen - 50 mg / 850 mg - metformiini ja vildagliptiini
vildagliptin/metformin ratiopharm 50 mg / 1000 mg tabletti, kalvopäällysteinen
teva b.v. - metformin hydrochloride, vildagliptin - tabletti, kalvopäällysteinen - 50 mg / 1000 mg - metformiini ja vildagliptiini
vildagliptin/metformin stada 50 mg / 1000 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - metformin hydrochloride, vildagliptin - tabletti, kalvopäällysteinen - 50 mg / 1000 mg - metformiini ja vildagliptiini
vildagliptin/metformin stada 50 mg / 850 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - metformin hydrochloride, vildagliptin - tabletti, kalvopäällysteinen - 50 mg / 850 mg - metformiini ja vildagliptiini
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptiini, metformiinihydrokloridia - diabetes mellitus, tyyppi 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 käytettävissä olevista tiedoista eri yhdistelmistä).
vildagliptin krka 50 mg tabletti
krka, d.d., novo mesto - vildagliptin - tabletti - 50 mg - vildagliptiini
vildagliptin ratiopharm 50 mg tabletti
teva b.v. - vildagliptin - tabletti - 50 mg - vildagliptiini